| Name | Goflikicept |
|---|
| Description | Goflikicept (RPH 104) is a hybrid protein that selectively binds and inactivates both circulating IL-1ß and IL-1α. Goflikicept has the potential for the research of ST-segment elevation myocardial infarction (STEMI)[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |